Russell Investments Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.13K Sell
129
-3,229
-96% -$178K ﹤0.01% 3388
2025
Q1
$162K Buy
3,358
+3,329
+11,479% +$161K ﹤0.01% 2648
2024
Q4
$1.12K Buy
29
+5
+21% +$193 ﹤0.01% 3515
2024
Q3
$1.08K Sell
24
-1,192
-98% -$53.6K ﹤0.01% 3472
2024
Q2
$42.1K Hold
1,216
﹤0.01% 2801
2024
Q1
$35.2K Buy
+1,216
New +$35.2K ﹤0.01% 2708
2023
Q4
Sell
-12
Closed -$200 3288
2023
Q3
$200 Sell
12
-43,510
-100% -$725K ﹤0.01% 3497
2023
Q2
$1.2M Sell
43,522
-56,564
-57% -$1.56M ﹤0.01% 1840
2023
Q1
$2.3M Sell
100,086
-98,883
-50% -$2.27M ﹤0.01% 1496
2022
Q4
$2.17M Sell
198,969
-31,878
-14% -$348K ﹤0.01% 1542
2022
Q3
$1.94M Sell
230,847
-58,715
-20% -$494K ﹤0.01% 1562
2022
Q2
$2.29M Buy
289,562
+106,446
+58% +$841K ﹤0.01% 1511
2022
Q1
$4.34M Buy
183,116
+19,527
+12% +$462K 0.01% 1241
2021
Q4
$5.59M Buy
163,589
+86,587
+112% +$2.96M 0.01% 1184
2021
Q3
$1.36M Buy
77,002
+22,998
+43% +$407K ﹤0.01% 2049
2021
Q2
$2.42M Buy
54,004
+3,271
+6% +$147K ﹤0.01% 1790
2021
Q1
$1.31M Sell
50,733
-4,327
-8% -$112K ﹤0.01% 2122
2020
Q4
$1.11M Sell
55,060
-51,292
-48% -$1.03M ﹤0.01% 2075
2020
Q3
$2.08M Sell
106,352
-75,384
-41% -$1.47M ﹤0.01% 1661
2020
Q2
$3.21M Buy
181,736
+77,296
+74% +$1.36M 0.01% 1361
2020
Q1
$736K Buy
104,440
+56,872
+120% +$401K ﹤0.01% 1994
2019
Q4
$334K Sell
47,568
-29,267
-38% -$205K ﹤0.01% 2537
2019
Q3
$926K Buy
+76,835
New +$926K ﹤0.01% 2038
2018
Q4
Sell
-5,900
Closed -$61K 3014
2018
Q3
$61K Buy
+5,900
New +$61K ﹤0.01% 2811